Over the last 13 months, Sanofi…
Over the last 13 months, Sanofi and Regeneron have revved [...]
A cystic fibrosis buyers group has…
A cystic fibrosis buyers group has resurfaced in a bid [...]
Just as Adverum’s cash reserves…
Just as Adverum’s cash reserves were running dry, Eli Lilly [...]
Last year, Japan’s Renalys picked…
Last year, Japan’s Renalys picked up certain Asian rights to [...]
Biogen plans to beef up its…
Biogen plans to beef up its early-stage immunology pipeline by [...]
Sanofi has dropped its respiratory…
Sanofi has dropped its respiratory syncytial virus vaccine for toddlers [...]
After a negative advisory…
After a negative advisory committee vote and a postponed approval [...]
Ophthalmology biotech veteran…
Ophthalmology biotech veteran Gregory Kunst has found his next venture [...]
Inhibrx Biosciences’ antibody…
Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 [...]
The company expects sales in the…
The company expects sales in the second half of the [...]